HomeCompareMEJHY vs ARCC

MEJHY vs ARCC: Dividend Comparison 2026

MEJHY yields 2.82% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEJHY wins by $39.9K in total portfolio value· pulled ahead in Year 3
10 years
MEJHY
MEJHY
● Live price
2.82%
Share price
$12.04
Annual div
$0.34
5Y div CAGR
35.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.4K
Annual income
$14,851.41
Full MEJHY calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — MEJHY vs ARCC

📍 MEJHY pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEJHYARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEJHY + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEJHY pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEJHY
Annual income on $10K today (after 15% tax)
$240.03/yr
After 10yr DRIP, annual income (after tax)
$12,623.70/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, MEJHY beats the other by $12,622.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEJHY + ARCC for your $10,000?

MEJHY: 50%ARCC: 50%
100% ARCC50/50100% MEJHY
Portfolio after 10yr
$44.5K
Annual income
$7,426.28/yr
Blended yield
16.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

MEJHY
No analyst data
Altman Z
3.4
Piotroski
6/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEJHY buys
0
ARCC buys
13
PoliticianChamberTickerTypeAmountDate
John Fetterman🏛 Senate$ARCC▲ Buy$1,001 - $15,0002025-09-09
John Fetterman🏛 Senate$ARCC▼ Sell$1,001 - $15,0002025-09-04
Ashley Moody🏛 Senate$ARCC▲ Buy$15,001 - $50,0002025-04-04
John Fetterman🏛 Senate$ARCC▲ Buy$1,001 - $15,0002025-02-18
Dave McCormick🏛 Senate$ARCC▲ Buy$250,001 - $500,0002025-01-17
Pete Sessions🏢 House$ARCC▼ Sell$1,001 - $15,0002023-11-01
Pete Sessions🏢 House$ARCC▲ Buy$569.252023-10-06
Pete Sessions🏢 House$ARCC▲ Buy$0 - $1,0002023-10-06
Pete Sessions🏢 House$ARCC▲ Buy$155.922023-08-15
Pete Sessions🏢 House$ARCC▲ Buy$0 - $1,0002023-08-15
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEJHYARCC
Forward yield2.82%10.65%
Annual dividend / share$0.34$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.5%-50%
Portfolio after 10y$64.4K$24.5K
Annual income after 10y$14,851.41$1.14
Total dividends collected$39.5K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: MEJHY vs ARCC ($10,000, DRIP)

YearMEJHY PortfolioMEJHY Income/yrARCC PortfolioARCC Income/yrGap
1$11,083$382.64$11,373$532.74$290.00ARCC
2$12,395$537.02$12,608$279.46$213.00ARCC
3← crossover$14,024$760.62$13,809$142.90+$215.00MEJHY
4$16,095$1,089.74$15,042$72.20+$1.1KMEJHY
5$18,806$1,583.83$16,341$36.27+$2.5KMEJHY
6$22,465$2,343.46$17,732$18.18+$4.7KMEJHY
7$27,583$3,545.20$19,231$9.10+$8.4KMEJHY
8$35,026$5,512.21$20,851$4.55+$14.2KMEJHY
9$46,342$8,864.01$22,605$2.28+$23.7KMEJHY
10$64,438$14,851.41$24,504$1.14+$39.9KMEJHY

MEJHY vs ARCC: Complete Analysis 2026

MEJHYStock

Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter and margarine, cream, ice cream, ready meals, chocolates, gummy products, chewing gums, sports nutrition products, infant formula, liquid diet, beauty supplements, OTC medicines, feed stuffs, corn sweeteners, and sugar, as well as transportation and distribution services. The company also offers drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and animal vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, disinfectants, oral administration, insecticides, anthelmintic, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents. In addition, it provides insecticides, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.

Full MEJHY Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this MEJHY vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEJHY vs SCHDMEJHY vs JEPIMEJHY vs OMEJHY vs KOMEJHY vs MAINMEJHY vs HTGCMEJHY vs GBDCMEJHY vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.